LifeStance Health Group, Inc. (NASDAQ:LFST) Sees Significant Increase in Short Interest

LifeStance Health Group, Inc. (NASDAQ:LFST) was the recipient of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 13,430,000 shares, an increase of 12.2% from the September 15th total of 11,970,000 shares. Based on an average daily volume of 1,640,000 shares, the days-to-cover ratio is presently 8.2 days. Currently, 12.1% of the shares of the company are short sold.

LifeStance Health Group Trading Down 0.4 %

Shares of LifeStance Health Group stock opened at $7.10 on Wednesday. The business has a fifty day simple moving average of $6.52 and a 200-day simple moving average of $6.08. The firm has a market cap of $2.71 billion, a price-to-earnings ratio of -14.79 and a beta of 1.24. LifeStance Health Group has a fifty-two week low of $4.64 and a fifty-two week high of $9.20. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.20.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings data on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. LifeStance Health Group had a negative net margin of 13.05% and a negative return on equity of 10.51%. The company had revenue of $312.30 million during the quarter, compared to analyst estimates of $305.85 million. During the same quarter last year, the firm posted ($0.13) EPS. The business’s revenue for the quarter was up 20.3% on a year-over-year basis. On average, equities analysts forecast that LifeStance Health Group will post -0.24 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on LFST shares. UBS Group cut their price objective on shares of LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a research note on Thursday, August 15th. Barclays dropped their price target on shares of LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating on the stock in a research report on Friday, August 9th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $8.25.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Ann Varanakis sold 5,269 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $6.28, for a total value of $33,089.32. Following the sale, the insider now owns 263,007 shares in the company, valued at approximately $1,651,683.96. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 6.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Point72 Asset Management L.P. purchased a new position in LifeStance Health Group in the 2nd quarter worth about $4,326,000. Dimensional Fund Advisors LP increased its position in shares of LifeStance Health Group by 82.0% in the second quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company’s stock worth $4,991,000 after acquiring an additional 457,930 shares in the last quarter. Magnetar Financial LLC acquired a new stake in shares of LifeStance Health Group during the second quarter valued at approximately $762,000. TD Asset Management Inc purchased a new stake in shares of LifeStance Health Group in the 2nd quarter valued at approximately $623,000. Finally, Sei Investments Co. acquired a new position in LifeStance Health Group in the 2nd quarter worth approximately $477,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.